BioLife Solutions, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$19M
Cost of Revenue
—
Gross Profit↑+32.7% +$12M
$49M
R&D↑+43.1% +$816K
$3M
D&A↓-72.1% -$676K
$261K
Operating Income↑+78.7% +$329K
$-89K
EBITDA↓-72.1% -$676K
$261K
Interest Expense
$833K
Interest Income
—
Other Income/Expense↑+458.1% +$2M
$1M
Pretax Income↑+227.6% +$1M
$703K
Tax Provision↑+202.5% +$162K
$82K
Net Income↑+136.5% +$2M
$621K
Gross Margin
259.4%
Operating Margin↑+1.6pts
-0.3%
Net Margin↑+10.2pts
2.2%
Effective Tax Rate↓-2.9pts
11.7%
Deferred Tax Liabilities↓-100.0% -$24K
$0
DTA Valuation Allowance↓-74.7% -$8M
$3M
NOL Carryforwards
$112M
ETR (Continuing Operations)↓-0.8pts
-0.4%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-8.0pts
-0.7%
ETR Foreign Differential (pp)
-0.3%
Operating Lease Cost
$496K
Revenue YoY Variation↑+40.5pts
31.2%
Income YoY Variation↓-18.6pts
78.7%
Revenue QoQ Variation
-33.1%
Income QoQ Variation↑+31.5pts
99.5%